Phenotypic Characterization of a Mouse Model of Juvenile Neuronal Ceroid Lipofuscinosis
Overview
Affiliations
Juvenile neuronal ceroid lipofuscinosis (JNCL) is an autosomal recessively inherited neurodegenerative disorder that results from mutations in the CLN3 gene. JNCL is characterized by accumulation of autofluorescent lysosomal storage bodies, vision loss, seizures, progressive cognitive and motor decline, and premature death. Studies were undertaken to characterize the neuronal ceroid lipofuscinosis phenotype in a Cln3 knockout mouse model. Progressive accumulation of autofluorescent storage material was observed in brain and retina of affected mice. The Cln3(-/-) mice exhibited progressively impaired inner retinal function, altered pupillary light reflexes, losses of inner retinal neurons, and reduced brain mass. Behavioral changes included reduced spontaneous activity levels and impaired learning and memory. In addition, Cln3(-/-) mice had significantly shortened life spans. These phenotypic features indicate that the mouse model will be useful for investigating the mechanisms underlying the disease pathology in JNCL and provide quantitative markers of disease pathology that can be used for evaluating the efficacies of therapeutic interventions.
Genetic and Cellular Basis of Impaired Phagocytosis and Photoreceptor Degeneration in CLN3 Disease.
Han J, Chear S, Talbot J, Swier V, Booth C, Reuben-Thomas C Invest Ophthalmol Vis Sci. 2024; 65(13):23.
PMID: 39535788 PMC: 11563035. DOI: 10.1167/iovs.65.13.23.
A novel porcine model of CLN3 Batten disease recapitulates clinical phenotypes.
Swier V, White K, Johnson T, Wang X, Han J, Pearce D Dis Model Mech. 2023; 16(8).
PMID: 37305926 PMC: 10434985. DOI: 10.1242/dmm.050038.
A mouse mutant deficient in both neuronal ceroid lipofuscinosis-associated proteins CLN3 and TPP1.
Sleat D, Banach-Petrosky W, Larrimore K, Nemtsova Y, Wiseman J, Najafi A J Inherit Metab Dis. 2023; 46(4):720-734.
PMID: 37078466 PMC: 10330656. DOI: 10.1002/jimd.12619.
Early postnatal administration of an AAV9 gene therapy is safe and efficacious in CLN3 disease.
Johnson T, Brudvig J, Likhite S, Pratt M, White K, Cain J Front Genet. 2023; 14:1118649.
PMID: 37035740 PMC: 10080320. DOI: 10.3389/fgene.2023.1118649.
Differential gene expression analysis following olfactory learning in honeybee (Apis mellifera L.).
Raza M, Anwar M, Husain A, Rizwan M, Li Z, Nie H PLoS One. 2022; 17(2):e0262441.
PMID: 35139088 PMC: 8827436. DOI: 10.1371/journal.pone.0262441.